AUTL logo

AUTL
Autolus Therapeutics Ltd - ADR

3,620
Mkt Cap
$364.62M
Volume
1.66M
52W High
$2.70
52W Low
$1.11
PE Ratio
-1.62
AUTL Fundamentals
Price
$1.37
Prev Close
$1.43
Open
$1.43
50D MA
$1.52
Beta
1.36
Avg. Volume
1.57M
EPS (Annual)
-$0.8652
P/B
1.83
Rev/Employee
$15,648.00
$307.41
Loading...
Loading...
News
all
press releases
Mak Capital One LLC Buys 9,062,518 Shares of Autolus Therapeutics PLC Sponsored ADR $AUTL
Mak Capital One LLC lifted its stake in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) by 53.5% in the third quarter, according to the company in its most recent disclosure with...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Autolus Therapeutics (AUTL) Projected to Post Earnings on Thursday
Autolus Therapeutics (NASDAQ:AUTL) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 19. (View Earnings Report at...
MarketBeat·11d ago
News Placeholder
Autolus Therapeutics Touts $75M Year-1 Obe-cel Launch, Sees $120M-$135M Revenue in 2026
Autolus Therapeutics (NASDAQ:AUTL) Chief Executive Officer Christian Itin told conference attendees the company is entering its second year as a commercial-stage business following the launch of its...
MarketBeat·17d ago
News Placeholder
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of "Hold" by Brokerages
Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) have received a consensus recommendation of "Hold" from the seven brokerages that are presently covering the stock...
MarketBeat·18d ago
News Placeholder
Traders Buy Large Volume of Autolus Therapeutics Call Options (NASDAQ:AUTL)
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) was the target of unusually large options trading activity on Monday. Traders purchased 2,496 call options on the stock. This...
MarketBeat·27d ago
News Placeholder
Q1 Earnings Forecast for AUTL Issued By HC Wainwright
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Autolus Therapeutics in a research report issued...
MarketBeat·1mo ago
News Placeholder
What is HC Wainwright's Estimate for AUTL FY2025 Earnings?
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) - Investment analysts at HC Wainwright issued their FY2025 earnings per share (EPS) estimates for shares of Autolus Therapeutics in...
MarketBeat·1mo ago
News Placeholder
Autolus Therapeutics (NASDAQ:AUTL) Rating Increased to Strong-Buy at HC Wainwright
HC Wainwright raised shares of Autolus Therapeutics to a "strong-buy" rating in a report on Tuesday...
MarketBeat·1mo ago
News Placeholder
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of "Hold" by Brokerages
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) has been given an average recommendation of "Hold" by the six brokerages that are presently covering the stock, Marketbeat...
MarketBeat·1mo ago
News Placeholder
New Strong Sell Stocks for January 30th
TSE, PAC and AUTL have been added to the Zacks Rank #5 (Strong Sell) List on January 30th, 2026.
Zacks·2mo ago
<
1
2
...
>

Latest AUTL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.